-
HEALTH UTILITY VALUES AMONG MIDDLE-AGED AND OLDER ADULTS ACROSS SEVEN MAJOR GEOGRAPHICAL REGIONS IN CHINA: EVIDENCE FROM CHARLS 2020
Feb 25, 2026, 14:41 PM -
AI-ENABLED VIRTUAL REALITY REHABILITATION: A HEALTH ECONOMIC FRAMEWORK FOR NEURO-ONCOLOGY
Feb 25, 2026, 14:41 PM -
FROM TEXT TO SIGNAL: EVALUATING LLMS FOR VALID CASE IDENTIFICATION IN PHARMACOVIGILANCE
Feb 25, 2026, 14:41 PM -
DISABILITY AND ADHERENCE TO GLP-1 RECEPTOR AGONISTS AND SGLT2 INHIBITORS AMONG U.S. ADULTS WITH DIABETES: EVIDENCE FROM THE MEDICAL EXPENDITURE PANEL SURVEY
Feb 25, 2026, 14:41 PM -
UNDERSTANDING THE IMPACT AND BURDEN OF MENOPAUSE ON MULTIPLE SCLEROSIS THROUGH A TARGETED LITERATURE REVIEW
Feb 25, 2026, 14:41 PM -
REAL-WORLD PATTERNS OF CTDNA TESTING, MOLECULAR RESIDUAL DISEASE, AND TREATMENT AFTER RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER
Feb 25, 2026, 14:41 PM -
COST-UTILITY ANALYSIS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE VERSUS FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL FOR MODERATE-TO-VERY SEVERE COPD IN CHINA
Feb 25, 2026, 14:41 PM -
ECONOMIC EVALUATION OF BLINATUMOMAB PLUS CHEMOTHERAPY IN CHILDREN WITH STANDARD RISK B CELL ACUTE LYMPHOBLASTIC LEUKEMIA AT AVERAGE RISK OF RELAPSE IN HONG KONG
Feb 25, 2026, 14:41 PM -
COMPARATIVE ANALYSIS OF CAR T-CELL THERAPY ALONE VERSUS CAR T-CELL THERAPY WITH STEM CELL TRANSPLANT IN BLOOD CANCERS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL OUTCOMES
Feb 25, 2026, 14:41 PM -
THE ROLE OF SYSTEMIC INFLAMMATION IN THE ASSOCIATION OF OBESITY WITH MORTALITY AND HEALTH OUTCOMES AMONG COPD PATIENTS: A MEDIATION ANALYSIS
Feb 25, 2026, 14:41 PM -
MODELING THE LIFETIME BENEFITS OF ETEPLIRSEN IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY
Feb 25, 2026, 14:41 PM -
USE OF PRIOR AUTHORIZATION, STEP THERAPY, AND QUANTITY LIMITSIN THE UNITED STATES: A NATIONAL PHARMACY CLAIMS ANALYSIS
Feb 25, 2026, 14:41 PM -
UNDERSTANDING THE HUMANISTIC BURDEN OF SJÖGREN’S DISEASE (SJD): A SYSTEMATIC LITERATURE REVIEW (SLR)
Feb 25, 2026, 14:41 PM -
COST ANALYSIS AND HEALTHCARE RESOURCE UTILIZATION AFTER OPEN LIVER RESECTION FROM A RANDOMIZED CONTROL TRIAL
Feb 25, 2026, 14:41 PM -
TITLE: COST-UTILITY ANALYSIS OF CALCITONIN GENE-RELATED PEPTIDE ANTIBODIES FOR PATIENTS WITH CHRONIC MIGRAINE: A UNITED STATES PAYER PERSPECTIVE
Feb 25, 2026, 14:41 PM -
CHARACTERIZING THE U.S. MEDICAID POPULATION BY FEDERAL POVERTY LEVEL: DEMOGRAPHICS, REGIONAL PATTERNS, AND AFFORDABLE CARE ACT (ACA) EXPANSION STATUS TO ASSESS POLICY SHIFTS UNDER THE ONE BIG BEAUTIFUL BILL ACT (H.R.1)
Feb 25, 2026, 14:41 PM -
THE COST-EFFECTIVENESS ANALYSIS OF INATICABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS IN CHINA
Feb 25, 2026, 14:41 PM -
COST EFFECTIVENESS OF FIRSEKIBART FOR THE TREATMENT OF ACUTE GOUT PATIENTS UNSUITABLE FOR STANDARD THERAPY IN CHINA
Feb 25, 2026, 14:41 PM -
PATTERNS AND PREDICTORS OF ANTIDEPRESSANT USE AMONG ADULTS WITH DEPRESSION IN THE UNITED STATES
Feb 25, 2026, 14:41 PM -
NATURAL HISTORY, MANAGEMENT, AND BURDEN OF DISEASE IN ADULTS WITH NF1 AND SYMPTOMATIC INOPERABLE PLEXIFORM NEUROFIBROMA IN FRANCE
Feb 25, 2026, 14:41 PM
